Team:Slovenia/Sponsors
From 2008.igem.org
(Difference between revisions)
(18 intermediate revisions not shown) | |||
Line 78: | Line 78: | ||
<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a> | <a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a> | ||
<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a> | <a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a> | ||
+ | <a href="https://2008.igem.org/Team:Slovenia/Background/Immune_response" target="_self">Immune response</a> | ||
+ | <a href="https://2008.igem.org/Team:Slovenia/Background/Flagellin" target="_self">Flagellin</a> | ||
</div> | </div> | ||
</li> | </li> | ||
Line 94: | Line 96: | ||
<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a> | <a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a> | ||
<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a> | <a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a> | ||
+ | <a href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</a> | ||
</div> | </div> | ||
</li> | </li> | ||
Line 104: | Line 107: | ||
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a> | <a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a> | ||
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a> | <a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a> | ||
- | |||
<a href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</a> | <a href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</a> | ||
- | |||
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a> | <a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a> | ||
</div> | </div> | ||
Line 160: | Line 161: | ||
--> | --> | ||
<html><center> | <html><center> | ||
- | <font size=" | + | <font size="5" color="#C73E4A"><i>We would like to express our thanks to our sponsors:</i></font> |
- | </center></html> | + | </center><br /></html> |
Line 168: | Line 169: | ||
<html> | <html> | ||
+ | <p> | ||
<table width="100%" border="0" cellspacing="25" cellpadding="1" align="center"> | <table width="100%" border="0" cellspacing="25" cellpadding="1" align="center"> | ||
<tr> | <tr> | ||
Line 195: | Line 197: | ||
<td><div align="center"> | <td><div align="center"> | ||
- | <p><a href="http://www. | + | <p><a href="http://www.lek.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2008/5/5e/Lek.gif" width="150" height="100" /></a></p> |
- | <p> | + | <p> Lek - član skupine Sandoz</p> |
</div></td> | </div></td> | ||
<td><div align="center"> | <td><div align="center"> | ||
- | <p><a href="http://www. | + | <p><a href="http://www.arrs.gov.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2008/2/21/ARRS.gif" width="150" height="100" /></a></p> |
- | <p> | + | <p> Slovenian Research Agency</p> |
</div></td> | </div></td> | ||
</tr> | </tr> | ||
Line 207: | Line 209: | ||
<td><div align="center"> | <td><div align="center"> | ||
- | <p><a href="http://www. | + | <p><a href="http://www.ad-futura.si" target="_blank"><img src="https://static.igem.org/mediawiki/2008/3/38/Adfutura.gif" width="150" height="100" /></a></p> |
- | <p> | + | <p> Ad futura</p> |
</div></td> | </div></td> | ||
- | </tr> | + | |
+ | |||
+ | |||
+ | |||
+ | <td><div align="center"> | ||
+ | |||
+ | <p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2008/d/db/TollImmune.gif" width="300" height="62" /> | ||
+ | </p> | ||
+ | <p> </p> | ||
+ | </div></td> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | </tr> | ||
<tr> | <tr> | ||
</table> | </table> | ||
</html> | </html> | ||
- | + | <html><center> | |
+ | Roche d.o.o, MEDILINE d.o.o, Anthron d.o.o., Lotrič d.o.o, Mercator d.d., Fementas, Micro+Polo | ||
+ | </center><br/><br /></html> | ||
---- | ---- | ||
Line 229: | Line 249: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | < | + | </p> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</html> | </html> | ||
<!------------------------------- KONEC IGEM 2008 STRANI ------------------------------------------------------> | <!------------------------------- KONEC IGEM 2008 STRANI ------------------------------------------------------> |
Latest revision as of 11:13, 30 October 2008
|
||||||||
| ||||||||
|
||||||||
|
||||||||
|